Holen Sie sich die Stockscreener-App
9.61
4.54%
0.46
Tevogen Bio Holdings Inc Aktie (TVGN) Neueste Nachrichten
Tevogen Bio Holdings Inc. Q4 2025 Earnings: Narrower Loss Beats Expectations as Development Progress ContinuesROIC Trend Report - newsline.com
Tevogen Bio (TVGN) registers 375,000 shares for resale by Patel Family - Stock Titan
Tevogen Bio Q4 2025 Earnings: EPS Surprise Beat Amid Ongoing Operational ChallengesProfit Guidance Range - newsline.com
Number of shareholders of Tevogen Bio Holdings Inc. – NASDAQ:TVGNW - TradingView
Tevogen Bio Holdings Inc. Announces William Keane as Interim Head of New Healthcare Services Initiative, Exploring MSO and CRO Acquisitions - Quiver Quantitative
Tevogen weighs $100M in potential MSO, CRO revenue with new unit - Stock Titan
TVGN Q4 2025 Earnings: Narrowed Loss Per Share Exceeds Expectations, Shares RisePost-Earnings Reaction - newsline.com
Tevogen Bio Q4 2025 Earnings: EPS Surprise Beats Estimates Despite No Revenue, Shares RiseAnalyst Consensus Shift - newsline.com
TVGN Q4 2025 Earnings: Narrowed Loss Beats Expectations as Stock SurgesSlow Growth Warning - newsline.com
TEVOGEN BIO HOLDINGS INC (TVGN) Stock Chart - ChartMill
Why Is Tevogen Bio Holdings Inc. (TVGNW) Stock Down Today? - Meyka
Tevogen Bio Holdings Inc. (TVGN) Q4 2025 Earnings: Narrower-Than-Expected Loss as Clinical Pipeline AdvancesRevenue Beat Analysis - newsline.com
TVGN Q4 2025 Earnings: Narrower Loss Surprises as Tevogen Focuses on Pipeline ExecutionEarnings Cycle Outlook - newsline.com
Tevogen Shares Drop After $100 Million Revenue Target; Deal Risk Eyed - Bez Kabli
TVGN News | TEVOGEN BIO HOLDINGS INC (NASDAQ:TVGN) - ChartMill
Tevogen Bio Holdings Inc. Outlines Strategic Acquisition Initiatives Aiming for $100 Million in Annual Revenue - Quiver Quantitative
Tevogen Advances Strategic Acquisition Initiatives with Potential to Support Approximately $100 ... - Caledonian Record
Tevogen outlines biotech, AI and healthcare services vision - Stock Titan
Tevogen Bio Inc: Tevogen Advances Strategic Acquisition Initiatives with Potential to Support Approximately $100 Million in Combined Annual Revenue - FinanzNachrichten.de
Tevogen Bio Warrant (TVGNW) Holds at $0.04 with Modest UptickDividend Growth Stocks - newsline.com
Tevogen Bio Holdings (TVGN) Slides 10.5% as Selling Pressure IntensifiesMomentum Breakout Ideas - newsline.com
Tevogen Bio Warrants Hold Flat at $0.04 as Support and Resistance ConvergePrice Surge Stocks - The Legal Advocate
Tevogen Bio Holdings Q4 2025 Earnings: Narrower-than-Expected Loss Fails to Lift SharesInstitutional Grade Picks - Newser
TVGN Q4 2025 Earnings: Narrower-Than-Expected Loss but No Revenue Growth Keeps Stock Under PressureConsensus Beat Rate - The Legal Advocate
Tevogen Bio Holdings Warrant (TVGNW) Stalls at $0.04 as Trading Remains FlatMACD Signal Stocks - Newser
Tevogen Signs Letter of Intent to Evaluate Potential Acquisition of a Management Services Organization - The Manila Times
Tevogen Bio Holdings Inc. (TVGN) Stock: Jumps 11.74% on Potential Healthcare Expansion Deal - parameter.io
Tevogen Also Considering Other Transactions With a Focus on Life Sciences and Healthcare-Related Businesses - Moomoo
Tevogen Bio Holdings Inc. Signs Non-Binding Letter of Intent to Explore Strategic Healthcare Transaction - Quiver Quantitative
Tevogen explores MSO deal that could pave path to $100M - Stock Titan
Tevogen Bio Holdings Company Profile & Introduction - Moomoo
Letter to Shareholders from CEO Dr. Ryan Saadi - Sahm
TVGN Shares Updates on Operational Improvements and Strategic Go - GuruFocus
Tevogen reports reduced operating losses in 2025 and Q1 2026 By Investing.com - Investing.com Nigeria
Tevogen reports reduced operating losses in 2025 and Q1 2026 - Investing.com
Tevogen ‘working towards’ aligning long-term incentives, performance milestones - TipRanks
Tevogen Bio Holdings Inc. Reports Significant Operational Improvements and Strategic Growth Initiatives - Quiver Quantitative
Tevogen CEO details 51% loss cut and pursuit of new deals - Stock Titan
Tevogen Bio Holdings Inc. 1Q 2026: Revenue $0 Net loss $(5.45)M — 10-Q Summary - TradingView
Tevogen Bio (TVGN) Q1 loss narrows but cash, Nasdaq listing pressures grow - Stock Titan
Tevogen Bio Holdings Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
TVGN Technical Analysis | Trend, Signals & Chart Patterns | TEVOGEN BIO HOLDINGS INC (NASDAQ:TVGN) - ChartMill
Number of shareholders of Tevogen Bio Holdings Inc. – NASDAQ:TVGN - TradingView
Tevogen (TVGN) Stock: Secures Fresh Capital to Advance Precision Healthcare Platform - parameter.io
Tevogen announces $3 million private investment at $8 per share, a 14% premium from latest market close - marketscreener.com
Tevogen Bio Holdings Inc. Secures $3 Million PIPE Financing from The Patel Family, LLP - Quiver Quantitative
Tevogen Announces $3 Million Private Investment at $8 Per Share, a 14% Premium from Latest ... - Caledonian Record
Existing backer pays 14% premium in Tevogen’s new $3M cash raise - Stock Titan
TradingKey - TradingKey
symbol__ Stock Quote Price and Forecast - CNN
The growth story Tevogen (TVGNW) is not telling investors (-2.53%) 2026-05-08Blue Chip Stocks - Newser
Tevogen (TVGN) Soars 11% as Firm Gears Up for AI Training Commercialization - Insider Monkey
5 Stocks Exploding in a Bleeding Market - Insider Monkey
Tevogen Bio Holdings Inc. 2025 Annual Report: Executive Compensation, Corporate Governance, Audit Committee, and Key Filings - Minichart
1.79%
0.89%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):